Category: Business

Le système Vivior est homologué marquage CE – Introduction sur le marché européen cette année

ZURICH–(BUSINESS WIRE)–Vivior a homologué son système en tant que dispositif médical de classe I et prévoit son introduction sur le marché en Suisse et dans l’Union européenne plus tard cette année. Vivior a déclaré à Swissmedic son produit, le Visual Behavior Monitor, et satisfait à toutes les exigences d’un dispositif médical de classe I selon la directive sur les dispositifs médicaux (MDD). Grâce à cette étape importante, Vivior est maintenant autorisée à vendre son système en Suisse et da

Riassunto: Il sistema di Vivior è notificato per il marchio CE – Quest'anno il lancio sul mercato europeo

ZURIGO–(BUSINESS WIRE)–Vivior ha notificato suo sistema come dispositivo medico di Classe I e sta pianificando l’introduzione sul mercato quest’anno in Svizzera e nell’Unione Europea. Vivior ha informato Swissmedic del proprio prodotto, il Visual Behavior Monitor, che soddisfa tutti i requisiti di un dispositivo medico di Classe I secondo la Direttiva dei dispositivi medici (Medical Device Directive, MDD). Avendo raggiunto questo importante traguardo, ora Vivior può vendere il proprio sistema

Blepharitis – 2019 Pipeline Insight Report: Analysis by Developmental Stage, Associated Indications, Route of Administration and Molecule Type – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Blepharitis – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Blepharitis development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indication

Retinal Vein Occlusion – Pipeline Insight, 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Retinal Vein Occlusion – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Retinal Vein Occlusion development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage,

Global Amblyopia Clinical Trials Review, H2, 2018 Featuring Herantis Pharma & Santen Pharmaceutical – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Amblyopia Global Clinical Trials Review, H2, 2018″ clinical trials has been added to ResearchAndMarkets.com’s offering. Amblyopia Global Clinical Trials Review, H2, 2018” provides an overview of Amblyopia clinical trials scenario. This report provides top line data relating to the clinical trials on Amblyopia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease